American Shared Hospital Services(AMS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 3 at 4:00 PM ET (Korea 11/4 06:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.26 | Insider Own | 33.66% | Shs Outstand | 6.6M | Perf Week | -3.15% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | 35.48% | Shs Float | 4.4M | Perf Month | -8.89% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | 0.01 | Inst Own | 7.6% | Short Float | 0.14% | Perf Quarter | -17.45% |
| Income | -0.00B | P/S | 0.27 | EPS this Y | 39.13% | Inst Trans | -28.66% | Short Ratio | 0.55 | Perf Half Y | -29.72% |
| Sales | 0.03B | P/B | 0.35 | EPS next 5Y | - | ROA | -3.06% | Short Interest | 0.01M | Perf YTD | -41.71% |
| Book/sh | 3.49 | P/C | 1.21 | EPS past 3/5Y | - 27.12% | ROE | -7.46% | 52W High | -48.54% ($2.39) | Perf Year | -41.43% |
| Cash/sh | 1.02 | P/FCF | 2.31 | Sales past 3/5Y | 12.46% 9.5% | ROIC | -6.51% | 52W Low | 1.65% ($1.21) | Perf 3Y | -48.96% |
| Dividend Est. | - | EV/EBITDA | 7.87 | EPS Y/Y TTM | 28.88% | Gross Margin | 17.07% | Volatility(W/M) | 4.05% 4.08% | Perf 5Y | -60.32% |
| Dividend TTM | - | EV/Sales | 0.81 | Sales Y/Y TTM | 3.97% | Oper. Margin | -7.44% | ATR (14) | 0.06 | Perf 10Y | -56.97% |
| Dividend Ex-Date | 2007/6/28 | Quick Ratio | 0.77 | EPS Q/Q | -76% | Profit Margin | -5.83% | RSI (14) | 36.86 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.77 | Sales Q/Q | 19.22% | SMA20 | -3.51% ($1.27) | Beta | 0.27 | Target Price | $4 |
| Payout | - | Debt/Eq | 0.89 | Earnings | 2026/8/13 | SMA50 | -10.56% ($1.38) | Rel Volume | 0.46 | Prev Close | $1.25 |
| Employees | 87 | LT Debt/Eq | 0.18 | EPS/Sales Surpr. | -250% 11.51% | SMA200 | -23.35% ($1.6) | Avg Volume(3M) | 0.01M | Price | $1.23 |
| IPO | 1984/7/3 | Option/Short | No/Yes | Trades | 23 | Volume | 5,090 | Change | -1.6% |
🧠 This is a US healthcare services company that provides high-cost radiation therapy equipment such as Gamma Knife, Proton Beam Radiation Therapy (PBRT), and Linear Accelerator (LINAC) to hospitals through joint ownership and operation arrangements. It is a small-cap company specializing in radiation-based cancer treatment that combines operating its own clinics with equipment leasing and management services.
Over the past 1 year, on the lower side
49% below its 1-year high.
Traded less than usual. That is 46% of its average volume.
AMS has weak earning power
Of every $100 in sales, $7.44 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +39.1% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $27. Peers typically go for $94. Compared with its own 4-year average, it is 25% cheaper now.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -60.3%. The S&P 500 did +62% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 7.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
DFSU Dimensional US Sustainability Core 1 ETF <0.01% 
DFAC U.S. Core Equity 2 Portfolio-ETF Class Shares <0.01% 
DFAT U.S. Targeted Value Portfolio-ETF Class Shares <0.01% 
VXF Vanguard Extended Market Index ETF <0.01% 
DFSV US Small Cap Value Portfolio ETF Class Shares <0.01% It ranks #47 of 48 in the industry
Based on market cap of $8M.
BTMD#43 biote Corp $40M PER 9.3 
PIII#44 P3 Health Partners Inc $28M PER - 
DCGO#45 DocGo Inc $25M PER - 
CCM#46 Concord Medical Services ADR $11M PER - AMS#47 American Shared Hospital Services $8M PER - 
FAQ
What kind of company is AMS?
AMS belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of AMS?
The market cap of AMS is approximately $8M, ranking 5,495 within its sector.
What is the 52-week high and low for AMS?
AMS has recorded a 52-week high of $2.39 and a low of $1.21.
